• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度尼西亚人群中HIV免疫无应答者体内促炎白细胞介素-6水平升高。

Elevated Levels of Pro-Inflammatory Interleukin-6 in HIV Immunological Non-Responders Among the Indonesian Population.

作者信息

Indrati Agnes Rengga, Kosasih Felicia Nathania, Fadhilah Fitri, Pratiwi Amelia, Muthiah Ummi, Logito Verina, Sumarpo Anton, Haryanto Jane, Munaya Shofa, Rosmiati Ni Made Dwi, Turbawaty Dewi Kartika, Wisaksana Rudi

机构信息

Department of Clinical Pathology, Faculty of Medicine, Universitas Padjadjaran-Hasan Sadikin General Hospital, Bandung 40161, Indonesia.

Doctoral Program, Faculty of Medicine, Universitas Padjadjaran, Bandung 40135, Indonesia.

出版信息

Diagnostics (Basel). 2025 Apr 10;15(8):959. doi: 10.3390/diagnostics15080959.

DOI:10.3390/diagnostics15080959
PMID:40310370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12026356/
Abstract

Approximately 10-35% of people living with HIV (PLHIV) on antiretroviral therapy (ART) fail to restore CD4 T cell counts, a state known as immunological non-responder (INR) characterized by persistent immune activation and elevated cytokine levels. : This study aimed to identify cytokines that can serve as biomarkers for immune activation and inflammation in INR patients. : We conducted a cross-sectional study comparing two groups: INRs (PLHIV on ART with viral suppression) and immunological responders (IRs). We analyzed 40 samples of virologically suppressed PLHIV, measuring CD4 T cell counts, viral load via RT-PCR, and cytokine levels through cytometric bead array (CBA). : The INR group exhibited significantly higher median serum levels of IL-6 (1.74 pg/mL vs. 0.94 pg/mL, = 0.016) and IL-10 (1.65 pg/mL vs. 0.92 pg/mL, = 0.03) compared to the IR group. : Elevated IL-6 and IL-10 levels may serve as potential markers to distinguish INR from IR patients with areas under the curve (AUC) of 0.731 and 0.707, respectively.

摘要

接受抗逆转录病毒疗法(ART)的艾滋病病毒感染者(PLHIV)中,约10%-35%的人未能恢复CD4 T细胞计数,这种状态被称为免疫无反应者(INR),其特征是持续的免疫激活和细胞因子水平升高。本研究旨在确定可作为INR患者免疫激活和炎症生物标志物的细胞因子。我们进行了一项横断面研究,比较了两组:免疫无反应者(接受ART且病毒得到抑制的PLHIV)和免疫反应者(IR)。我们分析了40份病毒得到抑制的PLHIV样本,通过逆转录聚合酶链反应(RT-PCR)测量CD4 T细胞计数和病毒载量,并通过细胞计数微球阵列(CBA)检测细胞因子水平。与IR组相比,INR组的血清白细胞介素-6(IL-6)中位数水平显著更高(1.74 pg/mL对0.94 pg/mL,P = 0.016),白细胞介素-10(IL-10)水平也显著更高(1.65 pg/mL对0.92 pg/mL,P = 0.03)。IL-6和IL-10水平升高可能作为区分INR和IR患者的潜在标志物,曲线下面积(AUC)分别为0.731和0.707。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/12026356/6403e735d4a7/diagnostics-15-00959-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/12026356/0a83a74480d6/diagnostics-15-00959-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/12026356/6403e735d4a7/diagnostics-15-00959-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/12026356/0a83a74480d6/diagnostics-15-00959-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f92/12026356/6403e735d4a7/diagnostics-15-00959-g002.jpg

相似文献

1
Elevated Levels of Pro-Inflammatory Interleukin-6 in HIV Immunological Non-Responders Among the Indonesian Population.印度尼西亚人群中HIV免疫无应答者体内促炎白细胞介素-6水平升高。
Diagnostics (Basel). 2025 Apr 10;15(8):959. doi: 10.3390/diagnostics15080959.
2
HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity.HIV 免疫无应答者的特征是广泛的免疫衰老和受损的淋巴细胞细胞因子产生能力。
Front Immunol. 2024 May 8;15:1350065. doi: 10.3389/fimmu.2024.1350065. eCollection 2024.
3
Association between CD4 T cell counts and gut microbiota and serum cytokines levels in HIV-infected immunological non-responders.HIV感染的免疫无应答者中CD4 T细胞计数与肠道微生物群及血清细胞因子水平之间的关联
BMC Infect Dis. 2021 Aug 3;21(1):742. doi: 10.1186/s12879-021-06491-z.
4
Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.鉴定少数尽管接受 ART 介导的病毒抑制但 CD4+ T 细胞仍极度下降的 HIV-1 感染患者。
JCI Insight. 2019 Apr 18;4(8). doi: 10.1172/jci.insight.127113.
5
Pathological proliferation: a potential mechanism for poor CD4 T cell recovery in people living with HIV.病理性增殖:HIV 感染者 CD4 T 细胞恢复不良的潜在机制。
Front Cell Infect Microbiol. 2024 Mar 27;14:1344778. doi: 10.3389/fcimb.2024.1344778. eCollection 2024.
6
Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.治疗后 HIV 阳性免疫无应答者中 T 细胞耗竭和衰老的标志物及其与血浆 TGF-β水平的关系。
Front Immunol. 2021 Mar 25;12:638010. doi: 10.3389/fimmu.2021.638010. eCollection 2021.
7
Thymic Exhaustion and Increased Immune Activation Are the Main Mechanisms Involved in Impaired Immunological Recovery of HIV-Positive Patients under ART.胸腺耗竭和免疫激活增加是 ART 下 HIV 阳性患者免疫恢复受损的主要机制。
Viruses. 2023 Feb 5;15(2):440. doi: 10.3390/v15020440.
8
Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppression.尽管长期病毒抑制,HIV 免疫无应答者外周 T 细胞仍被激活并归巢至肠道。
PLoS One. 2021 Jul 28;16(7):e0254149. doi: 10.1371/journal.pone.0254149. eCollection 2021.
9
The predictive role of CD4 cell count and CD4/CD8 ratio in immune reconstitution outcome among HIV/AIDS patients receiving antiretroviral therapy: an eight-year observation in China.CD4 细胞计数和 CD4/CD8 比值对接受抗反转录病毒治疗的 HIV/AIDS 患者免疫重建结果的预测作用:中国八年观察。
BMC Immunol. 2019 Aug 28;20(1):31. doi: 10.1186/s12865-019-0311-2.
10
Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation.免疫无应答者 PLHIV 抗逆转录病毒治疗起始后的脂蛋白谱。
Int J Mol Sci. 2022 Jul 22;23(15):8071. doi: 10.3390/ijms23158071.

本文引用的文献

1
The Enigmatic Interplay of Interleukin-10 in the Synergy of HIV Infection Comorbid with Preeclampsia.白细胞介素-10 在 HIV 感染合并子痫前期协同作用中的神秘相互作用。
Int J Mol Sci. 2024 Aug 30;25(17):9434. doi: 10.3390/ijms25179434.
2
Identification of cytokine signatures in HIV‑infected individuals with and without co‑infection.在合并或未合并其他感染的HIV感染者中细胞因子特征的鉴定。
Biomed Rep. 2024 Jul 10;21(3):131. doi: 10.3892/br.2024.1819. eCollection 2024 Sep.
3
HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity.
HIV 免疫无应答者的特征是广泛的免疫衰老和受损的淋巴细胞细胞因子产生能力。
Front Immunol. 2024 May 8;15:1350065. doi: 10.3389/fimmu.2024.1350065. eCollection 2024.
4
Thymic Exhaustion and Increased Immune Activation Are the Main Mechanisms Involved in Impaired Immunological Recovery of HIV-Positive Patients under ART.胸腺耗竭和免疫激活增加是 ART 下 HIV 阳性患者免疫恢复受损的主要机制。
Viruses. 2023 Feb 5;15(2):440. doi: 10.3390/v15020440.
5
Failure of CD4+ T-cell Recovery upon Virally-Effective cART: an Enduring Gap in the Understanding of HIV+ Immunological non-Responders.在病毒有效抑制 cART 的情况下,CD4+ T 细胞恢复失败:对 HIV+免疫无应答者的理解存在持久的差距。
New Microbiol. 2022 Jul;45(3):155-172.
6
Exploring alternative cytokines as potential biomarkers for latent tuberculosis infection in pregnant women.探讨替代细胞因子作为孕妇潜伏性结核感染潜在生物标志物的可能性。
PLoS One. 2022 Jul 8;17(7):e0270552. doi: 10.1371/journal.pone.0270552. eCollection 2022.
7
Clinical factors and outcomes associated with immune non-response among virally suppressed adults with HIV from Africa and the United States.与来自非洲和美国的 HIV 病毒抑制成人免疫无应答相关的临床因素和结局。
Sci Rep. 2022 Jan 24;12(1):1196. doi: 10.1038/s41598-022-04866-z.
8
Brief Report: Polymorphisms in TNF-α/TNFR1 Pathway Genes Are Associated With CD4+ T-Cell Recovery in HIV-1-Infected Individuals on Antiretroviral Therapy.简报:抗逆转录病毒治疗的 HIV-1 感染者中 TNF-α/TNFR1 通路基因多态性与 CD4+ T 细胞恢复相关。
J Acquir Immune Defic Syndr. 2021 Nov 1;88(3):322-327. doi: 10.1097/QAI.0000000000002761.
9
Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.治疗后 HIV 阳性免疫无应答者中 T 细胞耗竭和衰老的标志物及其与血浆 TGF-β水平的关系。
Front Immunol. 2021 Mar 25;12:638010. doi: 10.3389/fimmu.2021.638010. eCollection 2021.
10
Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies.样本量、功效和效应量再探:临床前、临床和实验室研究中简化而实用的方法。
Biochem Med (Zagreb). 2021 Feb 15;31(1):010502. doi: 10.11613/BM.2021.010502. Epub 2020 Dec 15.